OncoSec
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OncoSec and buy or sell other stocks, options, and ETFs commission-free!About ONCS
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.
CEORobert H. Arch, PhD
CEORobert H. Arch, PhD
Employees—
Employees—
HeadquartersEwing, New Jersey
HeadquartersEwing, New Jersey
Founded2008
Founded2008
Employees—
Employees—
ONCS Key Statistics
Market cap1.80K
Market cap1.80K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume436.50
Average volume436.50
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.31
52 Week high$1.31
52 Week low—
52 Week low—